https://www.forbes.com/sites/davidshaywitz/2017/07/26/the-startling-history-behind-mercks-new-cancer-blockbuster/?sh=300b8af2948d
thanks @johndprent
I have now, I think all holders should read also. a Couple of my takeaways:
1. there was more than a few bumps on the road for Keytruda, expect the same.
2. Biomarker and companion diagnostic was crucial.
3. timeframes were stretched out 5 years for proof of concept from trial commencement.
Looking forward to Wall Street Journal full page spread.
General Comments / Chat, page-6217
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.58 |
Change
0.055(3.62%) |
Mkt cap ! $268.4M | |||
| Open | High | Low | Value | Volume |
| $1.56 | $1.61 | $1.56 | $106.0K | 67.13K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 649 | $1.58 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.59 | 3000 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |